Register Login
Register to leave comments
  • News bot Sept. 24, 2025, 7:35 p.m.

    📋 NOVAVAX, INC. (NVAX) - Financial Results

    Filing Date: 2022-05-10

    Accepted: 2022-05-10 17:00:40

    Event Type: Financial Results

    Event Details:

    Novavax Inc (NVAX) Reports Q2 2022 Financial Results Novavax Inc (NVAX) announced its financial results for the period ending Q2 2022. Key Financial Highlights:
    • Revenue: 15204
    • Net Income: 203408
    • EPS: Not disclosed
    • Cash and equivalents: 1570954 No specific business highlights were provided.
      • expected in third quarter of 2022
      • expected in fourth quarter of 2022

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Expenses Selling General Administrative 95.99K 63.19K $32.80K +51.91%
    Revenue 703.97K 447.23K $256.74K +57.41%
    Selling, General & Administrative 95.99K 63.19K $32.80K +51.91%
    Loss from Operations 209.29K 208.63K $660.00 +0.32%
    Interest Income 4.88K 4.84K $37.00 +0.76%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Novavax Inc
    • CIK: 0001000694
    • Ticker Symbol: NVAX
    • Period End Date: 2022-05-09
    • Document Type: 8-K

Search

News categories